What This Year's Biggest Medicare Changes Mean for You

Why It Matters

The changes reshape seniors’ out‑of‑pocket expenses, access to services, and the value of private Advantage plans, directly influencing retirement budgeting and health‑care decisions.

Key Takeaways

• Part B premiums rise 9.7%, outpacing recent inflation.
• Medicare negotiates drug prices, cutting costs up to 50% for 10 drugs.
• Telehealth coverage extended through 2027, including audio‑only visits.
• Prior‑authorization pilot adds AI review for 17 procedures in six states.
• Advantage plan reimbursement set at 2.48%, may limit benefit enhancements.

Pulse Analysis

8% Social Security cost‑of‑living adjustment. For the roughly 70 million beneficiaries, the increase translates into an extra $70‑$80 per month for most enrollees, squeezing fixed incomes already pressured by rising health costs. The hike reflects broader federal budget constraints and the growing gap between health‑care inflation and the modest COLA that retirees receive, prompting many to re‑evaluate their coverage choices before the October open enrollment window.

A landmark provision of the 2022 Inflation Reduction Act finally allowed Medicare to negotiate prices for ten high‑cost Part D drugs, slashing out‑of‑pocket expenses by roughly 50% for beneficiaries who use medications such as Eliquis, Xarelto, Jardiance and Januvia. CMS estimates savings ranging from a few hundred to several thousand dollars per patient, depending on the drug and plan. Additional rounds slated for 2027 and 2028 will bring another 30 drugs under negotiation, creating a cascading effect that could reshape the pharmacy benefit landscape and incentivize prescribers to favor lower‑cost alternatives.

Telehealth, once a pandemic stopgap, earned a legislative extension through 2027, preserving video and audio‑only visits for all beneficiaries regardless of geography and expanding therapist‑led remote services. At the same time, CMS launched a six‑state pilot that subjects 17 procedures to AI‑assisted prior authorization, a move critics warn could curb access while aiming to curb spending. 48% reimbursement increase for Medicare Advantage plans may force insurers to trim supplemental benefits or raise cost‑shares, making the upcoming annual notice of change a critical document for seniors weighing original Medicare against private Advantage options.